Breast-specific gamma scans monitor chemo
Breast-specific gamma imaging is highly accurate in monitoring the response of breast cancers to neoadjuvant chemotherapy, according to a study presented at the American Society of Breast Surgeons' annual meeting in Las Vegas.
Breast-specific gamma imaging is highly accurate in monitoring the response of breast cancers to neoadjuvant chemotherapy, according to a study presented at the American Society of Breast Surgeons' annual meeting in Las Vegas.
In their 12-subject study, George Washington University Hospital researchers found gamma imaging accurately establishes tumor size within 5 mm after neoadjuvant chemotherapy. The pathologic size ranged from 2.6 cm to 2 mm postchemotherapy. In addition, the correlation coefficients are superior to those of other modalities, including physical exam, mammography, ultrasound, MRI, and FDG-PET, according to the authors.
The researchers compared gamma camera breast tumor images postchemotherapy with pathologic size at excision. They found the gamma imaging accurately reflected tumor size in all 12 patients.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 1st 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
August 1st 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 1st 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
